California Institute of Renal Research

La Mesa, California 92942

1 studies enrolling now · 18 studies all time

What they study most

Acute Kidney Injury, Anemia, Arteriovenous Fistula, Arteriovenous Graft, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Diseases, Cytomegalovirus (CMV) Infection, Cytomegalovirus Disease, Diabetes Mellitus, Type 2

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease. — Completed
• A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection — Completed
• A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) — Completed
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
• A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. — Completed
• A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients — Completed
• Study of Suramin in Subjects With Furosemide-Resistant AKI — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease — Completed
• A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria — Completed
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access — Stopped early
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access — Completed
• This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa — Completed
• A Phase 2 Extension Study of Study GCS-100-CS-4002 — Completed
• A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease — Completed
• A Phase 2 Extension of Study GCS-100-CS-4003 — Withdrawn before enrolling